Jennerex Says Early Data Shows Survival Benefit

Viruses that are genetically engineered to fight tumors, without harming healthy cells, may sound like sci-fi. But San Francisco-based Jennerex Biotherapeutics has started gathering some intriguing — albeit quite preliminary — clinical trial evidence that suggests this approach may be helping liver cancer patients live longer, Xconomy has learned.
Xconomy